RasGRP1 is a causal factor in the development of

Authors: Mehdi Eshraghi, Uri Nimrod Ramírez-Jarquín, Neelam Shahani, Tommaso Nuzzo, Arianna De Rosa, Supriya Swarnkar, Nicole Galli, Oscar Rivera, George Tsaprailis, Catherina Scharager-Tapia, Gogce Crynen, Qin Li, Marie-Laure Thiolat, Erwan Bezard, Alessandro Usiello, Srinivasa Subramaniam

Published: 2020-05-01

DOI: 10.1126/sciadv.aaz7001

Source: Full article


Abstract

A novel molecular target that signals abnormal involuntary movement in Parkinson’s disease treatment is discovered.